AKT1 and neoplasm: These compounds modulate key signaling pathways, including PI3K/AKT, NF-κB, Wnt/β-catenin, and p53/p21, leading to apoptosis induction, cell cycle arrest, inhibition of metastasis, and suppression of tumor progression.